Skip to main content
Top
Published in: American Journal of Clinical Dermatology 5/2001

01-10-2001 | Therapy in Practice

Delusions of Parasitosis

A Dermatologist’s Guide to Diagnosis and Treatment

Authors: Dr John Koo, Chai Sue Lee

Published in: American Journal of Clinical Dermatology | Issue 5/2001

Login to get access

Abstract

Delusions of parasitosis is a rare psychiatric disorder in which the patient has a fixed, false belief that he or she is infested by parasites. Even though it is a psychiatric disorder, these patients usually present to a dermatologist because they are convinced that they have a dermatological problem. Patients with delusions of parasitosis generally reject psychiatric referral. The diagnosis of delusions of parasitosis can often be made on the basis of the history alone, but it is important to make sure that the patient does not have a organic skin disorder, and the delusion is not secondary to another mental or physical illness. The current treatment of choice is the antipsychotic medication pimozide. The principal difficulty in management is convincing patients to take the drug. This results from the obvious discrepancy between the patients’ belief system and the clinician’s understanding of the situation. The most common adverse effects of pimozide are extrapyramidal symptoms such as stiffness and, less frequently, a special inner sense of restlessness called akathisia. Effective treatment of such extrapyramidal reactions includes benztropine 1 to 2mg up to 4 times daily as needed, or diphenhydramine 25mg 3 times daily as needed. Pimozide can have cardiotoxic effects at high dosages. Traditionally, it has been recommended to check pretreatment and post-treatment electrocardiograms even for patients who have no history or cardiac conduction abnormalities or arrhythmia. However, a more recent publication questions the need for this if the patient takes <10 mg/day, is not elderly, and has no history of cardiac arrhythmia. Effective dosages of pimozide for delusions of parasitosis have ranged from 1 to 10 mg/day. The lowest effective dosage of pimozide should be used for the shortest possible duration to minimize the risk of tardive dyskinesia developing in these patients. Significant improvements in quality of life have been achieved with successful treatment with pimozide. Atypical antipsychotics such as risperidone with a much safer adverse effect profile may prove to be effective for the treatment of delusions of parasitosis in the future.
Literature
1.
go back to reference Johnson G.C., Anton R.F. Delusions of parasitosis: differential diagnosis and treatment. South Med J 1985; 78: 914–918PubMedCrossRef Johnson G.C., Anton R.F. Delusions of parasitosis: differential diagnosis and treatment. South Med J 1985; 78: 914–918PubMedCrossRef
2.
go back to reference Morris M. Delusional infestation. Br J Psychiatry 1991; 159 Suppl. 14: 83–87CrossRef Morris M. Delusional infestation. Br J Psychiatry 1991; 159 Suppl. 14: 83–87CrossRef
3.
4.
go back to reference Reilly T.M. Delusional infestation. Br J Psychiatry 1988; 153 Suppl. 2: 44–46 Reilly T.M. Delusional infestation. Br J Psychiatry 1988; 153 Suppl. 2: 44–46
5.
go back to reference Koblenzer C.S. Psychocutaneous disease. Orlando (FL): Grune & Stratton 1987: 59–80, 108–130 Koblenzer C.S. Psychocutaneous disease. Orlando (FL): Grune & Stratton 1987: 59–80, 108–130
6.
go back to reference Wilson J.W., Miller H.E. Delusions of parasitosis (acarophobia). Arch Dermatol Syph 1946; 54: 39–56CrossRef Wilson J.W., Miller H.E. Delusions of parasitosis (acarophobia). Arch Dermatol Syph 1946; 54: 39–56CrossRef
7.
go back to reference Bishop E.R. Monosymptomatic hypochondriacal syndromes in dermatology. J Am Acad Dermatol 1983; 9: 152–158PubMedCrossRef Bishop E.R. Monosymptomatic hypochondriacal syndromes in dermatology. J Am Acad Dermatol 1983; 9: 152–158PubMedCrossRef
9.
go back to reference May W.W., Terpenning M.S. Delusional parasitosis in geriatric patients. Psychosomatics 1991; 32: 88–94PubMedCrossRef May W.W., Terpenning M.S. Delusional parasitosis in geriatric patients. Psychosomatics 1991; 32: 88–94PubMedCrossRef
10.
go back to reference Munro A. Delusional parasitosis: a form of monosymptomatic hypochondriacal psychosis. Semin Dermatol 1983; 2: 197–202 Munro A. Delusional parasitosis: a form of monosymptomatic hypochondriacal psychosis. Semin Dermatol 1983; 2: 197–202
12.
go back to reference Musalek M., Bach M., Passweg V., et al. The position of delusional parasitosis in psychiatric nosology and classification. Psychopathology 1990; 23: 115–124PubMedCrossRef Musalek M., Bach M., Passweg V., et al. The position of delusional parasitosis in psychiatric nosology and classification. Psychopathology 1990; 23: 115–124PubMedCrossRef
13.
go back to reference Retterstol N. Paranoid psychoses with hypochondriac delusions as the main delusion: a personal follow-up investigation. Acta Psychiatr Scand 1968; 44: 334–353PubMedCrossRef Retterstol N. Paranoid psychoses with hypochondriac delusions as the main delusion: a personal follow-up investigation. Acta Psychiatr Scand 1968; 44: 334–353PubMedCrossRef
14.
go back to reference Marneros A., Deister A., Rohde A. Delusional parasitosis: a comparative study to late-onset schizophrenia and organic mental disorders due to cerebral arteriosclerosis. Psychopathology 1988; 21: 267–274PubMedCrossRef Marneros A., Deister A., Rohde A. Delusional parasitosis: a comparative study to late-onset schizophrenia and organic mental disorders due to cerebral arteriosclerosis. Psychopathology 1988; 21: 267–274PubMedCrossRef
15.
go back to reference Driscoll M.S., Rothe M.J., Grant-Kels J.M., et al. Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach. J Am Acad Dermatol 1993; 29: 1023–1033PubMedCrossRef Driscoll M.S., Rothe M.J., Grant-Kels J.M., et al. Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach. J Am Acad Dermatol 1993; 29: 1023–1033PubMedCrossRef
16.
go back to reference Lyell A. Delusions of parasitosis. Semin Dermatol 1983; 2: 189–195 Lyell A. Delusions of parasitosis. Semin Dermatol 1983; 2: 189–195
17.
go back to reference Munro A. Monosymptomatic hypochondriacal psychosis. Br J Psychiatry 1988; 153 Suppl.: 37–40 Munro A. Monosymptomatic hypochondriacal psychosis. Br J Psychiatry 1988; 153 Suppl.: 37–40
18.
go back to reference Koo J. Psychodermatology. A practical manual for clinicians. Curr Probl Dermatol 1995; 7: 199–234CrossRef Koo J. Psychodermatology. A practical manual for clinicians. Curr Probl Dermatol 1995; 7: 199–234CrossRef
19.
go back to reference Pimozide. In: McEvoy GK, editor. American hospital formulary service drug information 92. Bethesda (MD): American Society of Hospital Pharmacists, 1992: 1290-4 Pimozide. In: McEvoy GK, editor. American hospital formulary service drug information 92. Bethesda (MD): American Society of Hospital Pharmacists, 1992: 1290-4
20.
go back to reference Lindskov R., Baadsgaard O. Delusions of infestation treated with pimozide: a followup study. Acta Derm Venereol Suppl (Stockh) 1985; 65: 267–270 Lindskov R., Baadsgaard O. Delusions of infestation treated with pimozide: a followup study. Acta Derm Venereol Suppl (Stockh) 1985; 65: 267–270
21.
go back to reference Koo J.Y.M., Pham C.T. Psychodermatology: practical guidelines on pharmacotherapy. Arch Dermatol 1992; 128: 381–388PubMedCrossRef Koo J.Y.M., Pham C.T. Psychodermatology: practical guidelines on pharmacotherapy. Arch Dermatol 1992; 128: 381–388PubMedCrossRef
22.
go back to reference Capellà D, Laporte J.R. Antipsychotic drugs. In: Dukes M.N.G., Aronson J.K., editors. Side effects of drugs annual 15. Amsterdam: Elsevier, 1991: 43–56 Capellà D, Laporte J.R. Antipsychotic drugs. In: Dukes M.N.G., Aronson J.K., editors. Side effects of drugs annual 15. Amsterdam: Elsevier, 1991: 43–56
23.
go back to reference Schatzberg A.F., Cole J.O., DeBattista C. Manual of clinical psychopharmacology. 3rd ed. Washington, DC: APA Press, 1997: 155 Schatzberg A.F., Cole J.O., DeBattista C. Manual of clinical psychopharmacology. 3rd ed. Washington, DC: APA Press, 1997: 155
24.
go back to reference Stahl S.M. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials. J Clin Psychiatry 1999; 60 Suppl. 10: 31–41PubMed Stahl S.M. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials. J Clin Psychiatry 1999; 60 Suppl. 10: 31–41PubMed
25.
go back to reference Brown C.S., Markowitz J.S., Moore T.R., et al. Atypical antipsychotics: part II adverse effects, drug interactions and costs. Ann Pharmacother 1999; 33: 210–217PubMedCrossRef Brown C.S., Markowitz J.S., Moore T.R., et al. Atypical antipsychotics: part II adverse effects, drug interactions and costs. Ann Pharmacother 1999; 33: 210–217PubMedCrossRef
26.
go back to reference Gallucci G., Beard G. Risperidone and the treatment of delusions of parasitosis in an elderly patient. Psychosomatics 1995 Nov–Dec; 36 (6): 578–580PubMedCrossRef Gallucci G., Beard G. Risperidone and the treatment of delusions of parasitosis in an elderly patient. Psychosomatics 1995 Nov–Dec; 36 (6): 578–580PubMedCrossRef
Metadata
Title
Delusions of Parasitosis
A Dermatologist’s Guide to Diagnosis and Treatment
Authors
Dr John Koo
Chai Sue Lee
Publication date
01-10-2001
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 5/2001
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200102050-00003

Other articles of this Issue 5/2001

American Journal of Clinical Dermatology 5/2001 Go to the issue

Review Article

Trichotillomania

BookReview

Book Reviews